To this end, we sought to interrogate the relationship between GFAP transcript expression and protein abundance in the brain with multiple AD-relevant outcomes, including amyloid and tau pathology as well as cognitive decline, while also assessing associations with concomitant pathways of injury. The gene discussed is MAPT; the disease is Mental deterioration.